Business Context and Reporting Period
Company: ILLUMINA, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: January 8, 2018
Event: Presentation of preliminary financial results for the quarter and year ended December 31, 2017, at the J.P. Morgan Healthcare Conference in San Francisco, California.
Key Financial Metrics
This Form 8-K serves as a notice of a presentation and does not contain specific numerical data for revenue, profit, cash flow, margins, debt, or liquidity within the filing text itself. The specific financial figures are contained in the attached transcript (Exhibit 99.1) and the reconciliation of non-GAAP guidance (Exhibit 99.2), which are incorporated by reference but not detailed in this summary document.
Material Changes
The filing does not explicitly list material changes versus prior periods. It references a presentation discussing preliminary results for the quarter and year ended December 31, 2017, but the specific variances are not enumerated in the text of this 8-K.
Guidance, Outlook, and Risks
- Guidance: The filing includes Exhibit 99.2, which provides a "Reconciliation of non-GAAP financial guidance for fiscal year 2018."
- Management Commentary: Management presented preliminary results at the J.P. Morgan Healthcare Conference. The full transcript is available on the company's website.
- Legal Status: The information in Item 2.02 is "furnished" and not "filed" under Section 18 of the Exchange Act. It shall not be incorporated by reference into registration statements unless expressly stated.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Transcript) for specific preliminary revenue and earnings figures for Q4 and FY 2017.
- Examine Exhibit 99.2 for the detailed reconciliation of non-GAAP financial guidance for fiscal year 2018.
- Verify the webcast availability on the company's Investor Information section, noted to remain available until April 8, 2018.
- Confirm that the "furnished" status of this report limits its use in future registration statements.